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Management of Type 1
Diabetes With a Very
Low–Carbohydrate Diet:
A Word of Caution
The public often looks to nutrition to
improve health, and reporting on
nutrition findings from the scientific
literature in the popular media often
reveals unproven benefits.1 Lennerz
et al2 present data collected via an
online community and conclude that
exceptional glycemic control in type 1
diabetes with a low risk for adverse
events is possible with a VLCD, and
research is needed to confirm the
generalizability of these findings.
Although it may be true that a VLCD
can be useful, we find the study of
Lennerz et al to fall well short of the
level of scientific evidence that merits
the media and professional attention
it seems to have garnered. The online
community was not a general type 1
diabetes community; rather, this was
a community following a specific type
of VLCD as promoted by the authors
of 1 book. And of the estimated 1900
community members, only 493
responded to an eligibility survey,
with 316 being included in analyses
(17%) and 148 with confirmed
medical data, representing only 8% of
the community.2 Of the small subset
of participants with self-reported
lipid concentrations (n 5 82; 4%
of the community), 62% had
dyslipidemia,2 which clearly is not
desirable.
We suspect that only individuals who
“believe” in the VLCD approach as
promoted by the authors of the book
would be in the community and
respond to this survey. We can
appreciate the effort made by the
authors to confirm the diagnosis of
type 1 diabetes, glycemic control (the
hemoglobin A1c), and adherence to
the diet; however, ultimately, those
efforts pale in comparison with
the problem of selection bias.
Furthermore, respondents who report
following the VLCD likely have other
attributes that are likely contributors
to excellent glycemic control, such as
careful monitoring of blood glucose
(blood sugar) levels, meticulous
attention to insulin administration,
vigilant exercise management, etc,
which can confuse or confound
attribution of the VLCD to glycemic
outcomes. Nutrition guidance for
patients and families living with type
1 diabetes must be made on the basis
of appropriate scientific evidence,
not on what more closely resembles
testimonials. We agree with the
authors that VLCDs may confer
benefits for some patients with type
1 diabetes and that rigorous science
is needed on this topic. The problem
we now face is that it is far too easy
for the potential benefits and safety
of VLCDs to be publicized broadly on
the basis of this report because
although findings were definitive,
they could be used to potentially
mislead the public and add to the
substantial confusion that exists
around whether VLCDs should be
used in type 1 diabetes.
Promulgating such methodologically
weak although enticing data broadly
through the media creates a risk that
patients or providers may pursue
such plans without adequate insulin
adjustment, resulting in serious
issues with hypoglycemia as well as
risk for nutritional deficiencies
without adequate monitoring
because of the substantially reduced
intake of fruits and vegetables while
on the VLCD.3,4
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